$199.99
Senolytic peptide for cellular senescence research.
FOXO4-DRI is a D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53. It was developed by researchers studying cellular senescence as a target for anti-aging interventions.
Research focuses on its senolytic properties – the ability to selectively eliminate senescent cells. Scientists study its potential for reversing age-related decline and treating age-related diseases.
This product is sold strictly for laboratory research use only. Not for human consumption. By purchasing, you acknowledge that you are at least 18 years of age and that this product will be used exclusively for legitimate research purposes. Peptides require reconstitution, instructions are not provided, nor are directions on dosing and usage. Products are intended strictly for research purposes by skilled professionals.